#VisualAbstract: Dolutegravir noninferior to a ritonavir-boosted protease inhibitor regimen for treating HIV
1. In the randomized controlled trial, dolutegravir treatment was noninferior to a regimen containing a ritonavir-boosted protease inhibitor (PI) for ...